- Home
- ATAI vs SMTI Comparison
ATAI vs SMTI Comparison
Compare ATAI & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- SMTI
- Stock Information
- Founded
- ATAI 2018
- SMTI 1982
- Country
- ATAI Germany
- SMTI United States
- Employees
- ATAI N/A
- SMTI N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- SMTI Medical/Dental Instruments
- Sector
- ATAI Health Care
- SMTI Health Care
- Exchange
- ATAI Nasdaq
- SMTI Nasdaq
- Market Cap
- ATAI 280.2M
- SMTI 288.2M
- IPO Year
- ATAI 2021
- SMTI N/A
- Fundamental
- Price
- ATAI $1.48
- SMTI $32.39
- Analyst Decision
- ATAI Strong Buy
- SMTI Strong Buy
- Analyst Count
- ATAI 4
- SMTI 2
- Target Price
- ATAI $9.00
- SMTI $47.00
- AVG Volume (30 Days)
- ATAI 2.9M
- SMTI 22.3K
- Earning Date
- ATAI 03-27-2025
- SMTI 05-12-2025
- Dividend Yield
- ATAI N/A
- SMTI N/A
- EPS Growth
- ATAI N/A
- SMTI N/A
- EPS
- ATAI N/A
- SMTI N/A
- Revenue
- ATAI $331,000.00
- SMTI $78,056,873.00
- Revenue This Year
- ATAI $80.07
- SMTI $35.26
- Revenue Next Year
- ATAI N/A
- SMTI $20.79
- P/E Ratio
- ATAI N/A
- SMTI N/A
- Revenue Growth
- ATAI N/A
- SMTI 24.66
- 52 Week Low
- ATAI $0.78
- SMTI $26.00
- 52 Week High
- ATAI $2.85
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- ATAI 41.75
- SMTI 44.91
- Support Level
- ATAI $1.37
- SMTI $30.81
- Resistance Level
- ATAI $1.50
- SMTI $32.90
- Average True Range (ATR)
- ATAI 0.14
- SMTI 1.55
- MACD
- ATAI -0.04
- SMTI -0.19
- Stochastic Oscillator
- ATAI 29.73
- SMTI 30.99
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.